Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris

American Journal of Cardiology

Volumn 92, Issue 4, 2003, Pages 363-367

  Desai, Akshay S ^a   Solomon, Daniel H ^a   Stone, Peter H ^a   Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEATH; ECONOMIC ASPECT; HEALTH CARE COST; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MULTIHOSPITAL SYSTEM; PATIENT; POPULATION; PRIORITY JOURNAL; RANDOMIZATION; REST; SCORING SYSTEM; ST SEGMENT ELEVATION; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

EID: 0042564737     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00650-7     Document Type: Article

References (14)

1. Solomon D.H., Stone P.H., Glynn R.J., Ganz D.A., Gibson C.M., Tracy R., Avorn J. Use of risk stratification to identify patients with unstable angina likeliest to benefit from an invasive versus conservative management strategy. J Am Coll Cardiol. 38:2001;969-976.
2. Antman E.M., Cohen M., Bernink P.J., McCabe C.H., Horacek T., Papuchis G., Mautner B., Corbalan R., Radley D., Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI a method for prognostication and therapeutic decision making . JAMA. 284:2000;835-842.
3. Cannon C.P., McCabe C.H., Stone P.H., Rogers W.J., Schactman M., Thompson B.W., Pearce D.J., Diver D.J., Kells C., Feldman T., et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q-wave myocardial infarction results of the TIMI III Registry ECG Ancillary Study . J Am Coll Cardiol. 30:1997;133-140.
4. Stone P.H., Thompson B., Anderson H.V., Kronenberg M.W., Gibson R.S., Rogers W.J., Diver D.J., Theroux P., Warnica J.W., Nasmith J.B., et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction the TIMI III Registry . JAMA. 275:1996;1104-1112.
5. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction results of the TIMI IIIB trial . Circulation. 89:1994;1545-1556.
6. Anderson H.V., Cannon C.P., Stone P.H., Williams D.O., McCabe C.H., Knatterud G.L., Thompson B., Willerson J.T., Braunwald E. One-year results of the Thrombolysis In Myocardial Infarction (TIMI) IIIB clinical trial a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction . J Am Coll Cardiol. 26:1995;1643-1650.
7. Medicare Provider Analysis and Review (MEDPAR). At: http://cms.hhs.gov/statistics/medpar/shortstay01drg.pdf. Accessed on June 17, 2003.
8. Heeschen C., Hamm C.W., Goldman B., Deu A., Langenbrink L., White H.D. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 354:1999;1757-1762.
9. Yeghiazarians Y., Braunstein J.B., Askari A., Stone P.H. Unstable angina pectoris. N Engl J Med. 342:2000;101-114.
10. Hamm C.W., Heeschen C., Goldman B., Vahanian A., Adgey J., Miguel C.M., Rutsch W., Berger J., Kootstra J., Simoons M.L. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. N Engl J Med. 340:1999;1623-1629.
11. Janzon M., Levin L.A., Swahn E. Cost effectiveness of an invasive strategy in unstable coronary artery disease; results from the FRISC II invasive trial. Eur Heart J. 23:2002;31-40.
12. Barnett P.G., Chen S., Boden W.E., Chow B., Every N.R., Lavori P.W., Hlatky M.A. Cost-effectiveness of a conservative, ischemia-guided management strategy after non-Q-wave myocardial infarction results of a randomized trial . Circulation. 105:2002;680-684.
13. Cannon C.P., Weintraub W.S., Demopoulos L.A., Vicari R., Frey M.J., Lakkis N., Neumann F.J., Robertson D.H., DeLucca P.T., DiBattiste P.M., Gibson C.M., Braunwald E. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 344:2001;1879-1887.
14. Mahoney E.M., Jurkovitz C.T., Chu H., Becker E.R., Culler S., Kosinski A.S., Robertson D.H., Alexander C., Nag S., Cook J.R., et al. TACTICS-TIMI 18 Investigators. Cost and cost-effectiveness of an early invasive vs conservative strategy for the treatment of unstable angina and non-ST-segment elevation myocardial infarction. JAMA. 288:2002;1851-1858.